Because of different tumor receptor status in ductal and lobular carcinomas, we explored associations between urinary cadmium and risk of ductal and lobular tumors restricting the analysis to ER+, PR+, ER+/PR+, HER2− and ER+/PR+/HER2− breast cancer (Table 3). This evidence concerns the gene PGR and breast cancer.